Smartsheet Market Cap

Glenmark Pharmaceuticals has a market cap or net worth of 583.53 billion as of August 1, 2025. Its market cap has increased by 46.58% in one year.

Market Cap

583.53B

Enterprise Value

591.21B

Revenue

134.35B

Ranking

n/a

PE Ratio

55.73

Stock Price

$2,066.95

Market Cap Chart

Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 583.53B, an increase of 50,672.92%. That is a compound annual growth rate of 29.41%.

Market Cap History

Date	Market Cap	% Change
Aug 1, 2025	583.53B	28.51%
Dec 31, 2024	454.07B	88.44%
Dec 29, 2023	240.96B	101.33%
Dec 30, 2022	119.68B	-19.75%
Dec 31, 2021	149.14B	7.10%
Dec 31, 2020	139.25B	42.03%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Reliance Industries	17.71T
HDFC Bank	15.43T
Bharti Airtel	11.30T
Tata Consultancy Services	10.99T
ICICI Bank	10.50T
State Bank of India	7,353.27B
Infosys	6,091.75B
Hindustan Unilever	5,923.79B

Market Cap Rankings